08/10
Headlines

Kristen Barton

Kristen Barton is a managing director and co-director of investment research. Kristen is also a senior research analyst focusing on agriculture & biotech companies. Prior to joining Tech Insider in 2010, Barton worked in equity research at RBC Capital Markets in Minneapolis, MN and Edward Jones in St. Louis, Mo. She was recognized for her stock picking in the 2012 Wall Street Journal "Best on the Street" publication.

Trader’s Buzz: AbbVie Inc. (NYSE:ABBV), Twenty-First Century Fox, Inc. (NASDAQ:FOXA), Brunswick Corporation (NYSE:BC), Cheniere Energy, Inc. (NYSEMKT:LNG), Forward Industries Inc. (NASDAQ:FORD)

Kristen Barton02 mins

On Dec. 23, AbbVie (NYSE:ABBV) will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Tuesday, Jan. 6, 2015. Richard A. Gonzalez, chairman and chief executive officer, will take part in a question and answer session at 2:15 p.m. Central time. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 18.90%…

Read More

Hot Runners: The AES Corporation (NYSE:AES), Twitter Inc (NYSE:TWTR), 1347 Property Insurance Holdings, Inc. (NASDAQ:PIH), Alibaba Group Holding (NYSE:BABA), Sony Corp (NYSE:SNE)

Kristen Barton02 mins

On Dec. 15, The AES Corporation (NYSE: AES) announced that Bernerd Da Santos has been appointed Senior Vice President and Chief Operating Officer, effective January 1, 2015. Mr. Da Santos has been serving as Acting Chief Operating Officer since December 1, 2014. The AES Corporation (NYSE:AES) belongs to Utilities sector. Its net profit margin is…

Read More

Big Movers: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Hercules Offshore, Inc. (NASDAQ:HERO), Uranium Energy Corp. (NYSEMKT:UEC), General Electric Company (NYSE:GE), Cognizant Technology Solutions (NASDAQ:CTSH)

Kristen Barton02 mins

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced positive interim results from two studies supporting a short duration, potentially best-in-disease regimen of its proprietary NS5A and nucleotide inhibitors, ACH-3102 and ACH-3422. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) belongs to Healthcare sector. Its weekly performance is -8.36%. On last trading day company shares ended up $11.84. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) distance…

Read More

Why Trader’s Are Watching: Curis, Inc. (NASDAQ:CRIS), BlackBerry Ltd (NASDAQ:BBRY), Goldfield Corp. (NYSEMKT:GV), Entergy Corporation (NYSE:ETR), Las Vegas Sands Corp. (NYSE:LVS)

Kristen Barton02 mins

On Dec. 18, Curis, Inc. (NASDAQ:CRIS) announced that the first patient has initiated treatment with CUDC-907 in a Phase 1 clinical trial in patients with advanced or relapsed solid tumors, including hormone receptor positive (HR+)/ HER2-negative breast cancer or midline carcinoma with certain NUT gene rearrangements. CUDC-907 is an oral, dual inhibitor of histone deacetylase…

Read More

Hot Watch List: Mobile Telesystems OJSC (NYSE:MBT), Sohu.com Inc. (NASDAQ:SOHU), SS&C Technologies Holdings, Inc. (NASDAQ:SSNC), Sanchez Energy Corporation (NYSE:SN), Alaska Air (NYSE:ALK)

Kristen Barton02 mins

Shares of Russian telecommunications company Mobile Telesystems OJSC (NYSE:MBT) recovered in trading Wednesday as the ruble rallied. Mobile Telesystems OJSC (NYSE:MBT) belongs to Technology sector. Its net profit margin is 30.20% and weekly performance is -32.32%. On last trading day company shares ended up $6.43. Mobile Telesystems OJSC (NYSE:MBT) distance from 50-day simple moving average…

Read More

Stocks News Alert: Himax Technologies (NASDAQ:HIMX), Aemetis, Inc. (NASDAQ:AMTX), BT Group plc (NYSE:BT), Layne Christensen Company (NASDAQ:LAYN), Rare Element Resources Ltd. (NYSEMKT:REE)

Kristen Barton02 mins

Himax Technologies, Inc. (NASDAQ:HIMX) has received a consensus recommendation of “Buy ” from the ten brokerages that are presently covering the stock, ARN reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and seven have issued a buy recommendation on the company. Himax Technologies, Inc. (ADR) (NASDAQ:HIMX)…

Read More